Wentworth Kerry
CHIEF REGULATORY OFFICER at NUVB; Chief Regulatory Officer at Flexion Therapeutics Inc; VP, Clinical, Reg & Qual at AGEN
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Jun 23, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- NUVBNuvation Bio Inc.CHIEF REGULATORY OFFICER
- Flexion Therapeutics IncChief Regulatory Officer
- AGENAGENUS INCVP, Clinical, Reg & Qual
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- NUVB299,750 shares
- AGEN73,892 shares
- Flexion Therapeutics Inc15,119 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AGENPlan not statedFeb 26, 2014 2014
Sold 5,000 shares at $5.00 ($25k)
Wentworth Kerry, VP, Clinical, Reg & Qual
Sold 8% of holdings ($312k position)57,410 shares leftFirst sale on recordFiling
- 2 Form 4 sale Flexion Therapeutics IncPlan not statedJan 3, 2019 +1772 days
Sold 622 shares at $12.36 ($8k)
Wentworth Kerry, Chief Regulatory Officer
Sold 5.3% of holdings ($146k position)11,207 shares leftFirst sale on recordFiling
- 3 Form 4 sale Flexion Therapeutics IncPlan not statedJan 3, 2020 +365 days
Sold 3,724 shares
Wentworth Kerry, Chief Regulatory Officer
Sold 6.9% of holdings50,061 shares leftFiling
- 4 Form 4 sale Flexion Therapeutics IncPlan not statedJan 5, 2021 +368 days
Sold 6,829 shares at $11.13 ($76k)
Wentworth Kerry, Chief Regulatory Officer
Sold 5.7% of holdings ($1.3M position)113,767 shares leftFiling
- 5 Form 4 sale Flexion Therapeutics IncPlan not statedJul 19, 2021 +195 days
Sold 3,944 shares at $6.45 ($25k)
Wentworth Kerry, Chief Regulatory Officer
Sold 2.7% of holdings ($931k position)140,362 shares leftFiling
- 6 Form 4 sale NUVBRoutineApr 6, 2026 +1722 days
Sold 200,000 shares at $4.52 ($904k)
Wentworth Kerry, CHIEF REGULATORY OFFICER
10b5-1 planSold 79.1% of holdings ($1.1M position)53,000 shares leftFirst sale on recordFiling
- 7 Form 4 sale NUVBRoutineApr 17, 2026 +11 days
Sold 36,750 shares at $5.01 ($184k)
Wentworth Kerry, CHIEF REGULATORY OFFICER
10b5-1 planSold 40.9% of holdings ($450k position)53,000 shares leftFiling
- 8 Form 4 sale NUVBRoutineJun 23, 2026 +67 days
Sold 63,000 shares at $6.02 ($379k)
Wentworth Kerry, CHIEF REGULATORY OFFICER
10b5-1 planSold 54.3% of holdings ($698k position)53,000 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Jun 24, 2026 | NUVB | CHIEF REGULATORY OFFICER | Form 4 sale | 63,000 | $379k | 54.3% | Routine | SEC |
| Apr 17, 2026 | Apr 21, 2026 | NUVB | CHIEF REGULATORY OFFICER | Form 4 sale | 36,750 | $184k | 40.9% | Routine | SEC |
| Apr 6, 2026 | Apr 8, 2026 | NUVB | CHIEF REGULATORY OFFICER | Form 4 sale | 200,000 | $904k | 79.1% | Routine | SEC |
| Jul 19, 2021 | Jul 20, 2021 | Flexion Therapeutics Inc | Chief Regulatory Officer | Form 4 sale | 3,944 | $25k | 2.7% | Plan not stated | SEC |
| Jan 5, 2021 | Jan 7, 2021 | Flexion Therapeutics Inc | Chief Regulatory Officer | Form 4 sale | 6,829 | $76k | 5.7% | Plan not stated | SEC |
| Jan 3, 2020 | Jan 7, 2020 | Flexion Therapeutics Inc | Chief Regulatory Officer | Form 4 sale | 3,724 | 6.9% | Plan not stated | SEC | |
| Jan 3, 2019 | Jan 4, 2019 | Flexion Therapeutics Inc | Chief Regulatory Officer | Form 4 sale | 622 | $8k | 5.3% | Plan not stated | SEC |
| Feb 26, 2014 | Feb 28, 2014 | AGEN | VP, Clinical, Reg & Qual | Form 4 sale | 5,000 | $25k | 8.0% | Plan not stated | SEC |
| Dec 29, 2011 | Dec 29, 2011 | AGEN | VP, Clinical, Reg, & Quality | Form 4 sale | 13,988 | $29k | 47.5% | Unusual | SEC |
| Dec 23, 2011 | Dec 23, 2011 | AGEN | VP, Clinical, Reg, & Quality | Form 4 sale | 6,016 | $13k | 17.0% | Plan not stated | SEC |
| Oct 26, 2010 | Oct 28, 2010 | AGEN | VP, Clin, Reg & Quality | Form 4 sale | 4,165 | $4k | 2.8% | Plan not stated | SEC |
| Sep 14, 2010 | Sep 14, 2010 | AGEN | Vp, Clin, Reg & Quality | Form 4 sale | 1,453 | $1k | 1.0% | Plan not stated | SEC |
| Jul 26, 2010 | Jul 28, 2010 | AGEN | VP, Clin, Reg & Quality | Form 4 sale | 4,165 | $3k | 2.9% | Plan not stated | SEC |
| Apr 26, 2010 | Apr 28, 2010 | AGEN | VP, Clin, Reg & Quality | Form 4 sale | 4,165 | $5k | 2.9% | Plan not stated | SEC |
| Sep 11, 2009 | Sep 14, 2009 | AGEN | VP, Clin, Reg & Quality | Form 4 sale | 1,367 | $3k | 1.3% | Plan not stated | SEC |
| Jul 16, 2009 | Jul 17, 2009 | AGEN | VP, Clin., Reg. & Qual. | Form 4 sale | 33,573 | $56k | 24.6% | Plan not stated | SEC |